(CWCO) Consolidated Water - Ratings and Ratios
Potable Water, Desalination Plants, Reverse Osmosis Systems, Water Treatment
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.49% |
| Yield on Cost 5y | 4.52% |
| Yield CAGR 5y | 10.12% |
| Payout Consistency | 94.3% |
| Payout Ratio | 50.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 31.5% |
| Value at Risk 5%th | 46.8% |
| Relative Tail Risk | -9.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.23 |
| Alpha | 32.62 |
| CAGR/Max DD | 0.98 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.528 |
| Beta | 0.265 |
| Beta Downside | 0.131 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.23% |
| Mean DD | 16.98% |
| Median DD | 18.94% |
Description: CWCO Consolidated Water December 27, 2025
Consolidated Water Co. Ltd. (NASDAQ:CWCO) operates a vertically integrated water business across the Cayman Islands, the Bahamas, the United States, and the British Virgin Islands, delivering potable water, wastewater treatment, and water-reuse services through its Retail, Bulk, Services, and Manufacturing segments.
Key performance indicators from the most recent filing show 2023 revenue of roughly $166 million, an operating margin of about 12 %, and a net debt-to-EBITDA ratio near 2.0×, indicating modest leverage for a utility-type asset base.
Primary growth drivers include rising water scarcity in the Caribbean, sustained tourism-related water demand, and U.S. infrastructure spending that fuels demand for outsourced water-treatment and desalination projects; the company’s reverse-osmosis technology positions it to capture a larger share of these expanding markets.
For a deeper dive into CWCO’s valuation metrics and peer comparison, you might explore the detailed analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (16.9m TTM) > 0 and > 6% of Revenue (6% = 7.85m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA -3.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 108.3% (prev 84.29%; Δ 24.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 35.2m > Net Income 16.9m (YES >=105%, WARN >=100%) |
| Net Debt (-120.3m) to EBITDA (24.5m) ratio: -4.92 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (16.0m) change vs 12m ago 0.34% (target <= -2.0% for YES) |
| Gross Margin 35.60% (prev 35.53%; Δ 0.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.80% (prev 66.62%; Δ -13.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3332 (EBITDA TTM 24.5m / Interest Expense TTM 5721 ) >= 6 (WARN >= 3) |
Altman Z'' 9.85
| (A) 0.55 = (Total Current Assets 169.9m - Total Current Liabilities 28.2m) / Total Assets 257.2m |
| (B) 0.45 = Retained Earnings (Balance) 116.1m / Total Assets 257.2m |
| (C) 0.08 = EBIT TTM 19.1m / Avg Total Assets 247.8m |
| (D) 4.05 = Book Value of Equity 125.6m / Total Liabilities 31.0m |
| Total Rating: 9.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.94
| 1. Piotroski 4.50pt |
| 2. FCF Yield 5.91% |
| 3. FCF Margin 19.95% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda -4.92 |
| 6. ROIC - WACC (= 0.79)% |
| 7. RoE 7.85% |
| 8. Rev. Trend 57.78% |
| 9. EPS Trend 50.32% |
What is the price of CWCO shares?
Over the past week, the price has changed by +2.21%, over one month by +5.37%, over three months by +6.69% and over the past year by +40.75%.
Is CWCO a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CWCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 42.5 | 19.4% |
| Analysts Target Price | 42.5 | 19.4% |
| ValueRay Target Price | 48 | 34.7% |
CWCO Fundamental Data Overview January 02, 2026
P/E Forward = 22.6244
P/S = 4.2972
P/B = 2.5514
P/EG = 2.2449
Beta = 0.501
Revenue TTM = 130.8m USD
EBIT TTM = 19.1m USD
EBITDA TTM = 24.5m USD
Long Term Debt = 34.8k USD (from longTermDebt, last quarter)
Short Term Debt = 729.5k USD (from shortTermDebt, last quarter)
Debt = 3.22m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -120.3m USD (from netDebt column, last quarter)
Enterprise Value = 441.9m USD (562.2m + Debt 3.22m - CCE 123.6m)
Interest Coverage Ratio = 3332 (Ebit TTM 19.1m / Interest Expense TTM 5721 )
FCF Yield = 5.91% (FCF TTM 26.1m / Enterprise Value 441.9m)
FCF Margin = 19.95% (FCF TTM 26.1m / Revenue TTM 130.8m)
Net Margin = 12.90% (Net Income TTM 16.9m / Revenue TTM 130.8m)
Gross Margin = 35.60% ((Revenue TTM 130.8m - Cost of Revenue TTM 84.3m) / Revenue TTM)
Gross Margin QoQ = 36.86% (prev 38.20%)
Tobins Q-Ratio = 1.72 (Enterprise Value 441.9m / Total Assets 257.2m)
Interest Expense / Debt = 0.03% (Interest Expense 901.0 / Debt 3.22m)
Taxrate = 12.58% (827.0k / 6.57m)
NOPAT = 16.7m (EBIT 19.1m * (1 - 12.58%))
Current Ratio = 6.03 (Total Current Assets 169.9m / Total Current Liabilities 28.2m)
Debt / Equity = 0.01 (Debt 3.22m / totalStockholderEquity, last quarter 220.4m)
Debt / EBITDA = -4.92 (Net Debt -120.3m / EBITDA 24.5m)
Debt / FCF = -4.61 (Net Debt -120.3m / FCF TTM 26.1m)
Total Stockholder Equity = 215.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.81% (Net Income 16.9m / Total Assets 257.2m)
RoE = 7.85% (Net Income TTM 16.9m / Total Stockholder Equity 215.1m)
RoCE = 8.86% (EBIT 19.1m / Capital Employed (Equity 215.1m + L.T.Debt 34.8k))
RoIC = 7.74% (NOPAT 16.7m / Invested Capital 215.2m)
WACC = 6.95% (E(562.2m)/V(565.4m) * Re(6.99%) + D(3.22m)/V(565.4m) * Rd(0.03%) * (1-Tc(0.13)))
Discount Rate = 6.99% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.93%
[DCF Debug] Terminal Value 84.79% ; FCFF base≈28.5m ; Y1≈34.2m ; Y5≈54.8m
Fair Price DCF = 83.17 (EV 1.20b - Net Debt -120.3m = Equity 1.33b / Shares 15.9m; r=6.95% [WACC]; 5y FCF grow 21.37% → 3.0% )
EPS Correlation: 50.32 | EPS CAGR: 47.09% | SUE: 0.62 | # QB: 0
Revenue Correlation: 57.78 | Revenue CAGR: 22.03% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.41 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.58 | Chg30d=-0.040 | Revisions Net=-2 | Growth EPS=+27.4% | Growth Revenue=+52.4%
Additional Sources for CWCO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle